These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

530 related articles for article (PubMed ID: 28238116)

  • 21. Immune related factors in pathogenesis of autism spectrum disorders.
    Szachta P; Skonieczna-Żydecka K; Adler G; Karakua-Juchnowicz H; Madlani H; Ignyś I
    Eur Rev Med Pharmacol Sci; 2016 Jul; 20(14):3060-72. PubMed ID: 27460736
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Autism spectrum disorders and natural killer cells: a review on pathogenesis and treatment.
    Ebrahimi Meimand S; Rostam-Abadi Y; Rezaei N
    Expert Rev Clin Immunol; 2021 Jan; 17(1):27-35. PubMed ID: 33191807
    [No Abstract]   [Full Text] [Related]  

  • 23. Transcranial magnetic stimulation in autism spectrum disorder: Challenges, promise, and roadmap for future research.
    Oberman LM; Enticott PG; Casanova MF; Rotenberg A; Pascual-Leone A; McCracken JT;
    Autism Res; 2016 Feb; 9(2):184-203. PubMed ID: 26536383
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serotonin mediated immunoregulation and neural functions: Complicity in the aetiology of autism spectrum disorders.
    Jaiswal P; Mohanakumar KP; Rajamma U
    Neurosci Biobehav Rev; 2015 Aug; 55():413-31. PubMed ID: 26021727
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The immune response in autism: a new frontier for autism research.
    Ashwood P; Wills S; Van de Water J
    J Leukoc Biol; 2006 Jul; 80(1):1-15. PubMed ID: 16698940
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Beyond the brain: A multi-system inflammatory subtype of autism spectrum disorder.
    Thom RP; Keary CJ; Palumbo ML; Ravichandran CT; Mullett JE; Hazen EP; Neumeyer AM; McDougle CJ
    Psychopharmacology (Berl); 2019 Oct; 236(10):3045-3061. PubMed ID: 31139876
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Periventricular white matter abnormalities and restricted repetitive behavior in autism spectrum disorder.
    Blackmon K; Ben-Avi E; Wang X; Pardoe HR; Di Martino A; Halgren E; Devinsky O; Thesen T; Kuzniecky R
    Neuroimage Clin; 2016; 10():36-45. PubMed ID: 26693400
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pathophysiology of autism spectrum disorders: revisiting gastrointestinal involvement and immune imbalance.
    Samsam M; Ahangari R; Naser SA
    World J Gastroenterol; 2014 Aug; 20(29):9942-51. PubMed ID: 25110424
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chromatographic and mass spectrometric techniques in studies on oxidative stress in autism.
    Kałużna-Czaplińska J; Jóźwik-Pruska J
    J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Apr; 1019():4-14. PubMed ID: 26776498
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bridging Autism Spectrum Disorders and Schizophrenia through inflammation and biomarkers - pre-clinical and clinical investigations.
    Prata J; Santos SG; Almeida MI; Coelho R; Barbosa MA
    J Neuroinflammation; 2017 Sep; 14(1):179. PubMed ID: 28870209
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Altered Microglia in the Amygdala Are Involved in Anxiety-related Behaviors of a Copy Number Variation Mouse Model of Autism.
    Shigemori T; Sakai A; Takumi T; Itoh Y; Suzuki H
    J Nippon Med Sch; 2015; 82(2):92-9. PubMed ID: 25959200
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Do animal models hold value in Autism spectrum disorder (ASD) drug discovery?
    Chadman KK; Fernandes S; DiLiberto E; Feingold R
    Expert Opin Drug Discov; 2019 Aug; 14(8):727-734. PubMed ID: 31132011
    [No Abstract]   [Full Text] [Related]  

  • 33. Anatomical likelihood estimation meta-analysis of grey and white matter anomalies in autism spectrum disorders.
    DeRamus TP; Kana RK
    Neuroimage Clin; 2015; 7():525-36. PubMed ID: 25844306
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immune system dysfunction and inflammation in aging
    Cerilli E; Dall'O GM; Chelini G; Catena B; Weinberger B; Bozzi Y; Pangrazzi L
    Front Immunol; 2024; 15():1447385. PubMed ID: 39308859
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A Pilot Proteomic Analysis of Salivary Biomarkers in Autism Spectrum Disorder.
    Ngounou Wetie AG; Wormwood KL; Russell S; Ryan JP; Darie CC; Woods AG
    Autism Res; 2015 Jun; 8(3):338-50. PubMed ID: 25626423
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Modern Biomarkers for Autism Spectrum Disorder: Future Directions.
    Jensen AR; Lane AL; Werner BA; McLees SE; Fletcher TS; Frye RE
    Mol Diagn Ther; 2022 Sep; 26(5):483-495. PubMed ID: 35759118
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neuroanatomical variation in autism spectrum disorder: A comprehensive review.
    Jumah F; Ghannam M; Jaber M; Adeeb N; Tubbs RS
    Clin Anat; 2016 May; 29(4):454-65. PubMed ID: 27004599
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The emerging roles of MicroRNAs in autism spectrum disorders.
    Fregeac J; Colleaux L; Nguyen LS
    Neurosci Biobehav Rev; 2016 Dec; 71():729-738. PubMed ID: 27793596
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cytokine aberrations in autism spectrum disorder: a systematic review and meta-analysis.
    Masi A; Quintana DS; Glozier N; Lloyd AR; Hickie IB; Guastella AJ
    Mol Psychiatry; 2015 Apr; 20(4):440-6. PubMed ID: 24934179
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Building a social neuroscience of autism spectrum disorder.
    Pelphrey KA; Yang DY; McPartland JC
    Curr Top Behav Neurosci; 2014; 16():215-33. PubMed ID: 24481546
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.